Why big pharma wants to collect 2 million genomes
For the head of AstraZeneca’s genomics initiative, the challenge is not just getting the sequences, but in putting them to use — wisely.
SE ORDENA RETROTRAER LOS PRECIOS DE LA MEDICINA PREPAGA
Hace 17 horas
.png)
No hay comentarios:
Publicar un comentario